Cell Growth & Differentiation, Vol 7, Issue 2 243-250, Copyright © 1996 by American Association of Cancer Research

ARTICLES

Constitutively active mitogen-activated protein kinase kinase 1 (MAPKK1) and MAPKK2 mediate similar transcriptional and morphological responses

SJ Mansour, JM Candia, KK Gloor and NG Ahn
Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder 80309, USA.

Both mitogen-activated protein kinase kinase 1 (MAPKK1) and MAPKK2 function downstream of the proto-oncogene product Raf in signaling pathways that affect cell proliferation and differentiation. The isoforms were previously shown to be differentially regulated in two significant ways: (a) MAPKK1, but not MAPKK2, was phosphorylated and inactivated by the cyclin-dependent kinase p34cdc2; and (b) p21 Ras formed a ternary complex with Raf/MAPKK1 but not with Raf/MAPKK2. To further characterize the regulation and function of the two isoforms, we compared their mode of activation by v-Mos and examined the transcriptional and morphological responses that they mediate in cultured mammalian cells. v-Mos enhanced the enzymatic activity of both isoforms to the same extent, by about 600-fold. Constitutively active MAPKK2 mutants were generated by introducing the same deletion and amino acid substitutions that have been shown to activate MAPKK1, suggesting that the conformational changes that lead to their activation are analogous. These mutants potentiated transcription from a promoter containing AP1-responsive elements and induced morphological transformation when expressed in mammalian cells, matching outcomes observed with constitutively active MAPKK1. The specific activity of p42 MAPK in the transformed cells was 3-fold higher than in cells expressing wild-type MAPKK, thereby implicating p42 MAPK as a common effector in vivo, and suggesting that sustained activation of p42 MAPK may represent a critical factor that contributes to the development of the transformed state. Altogether, the results demonstrate that the two isoforms elicit similar responses in vivo despite differences in their regulation.

This article has been cited by other articles:

				K. Maki and K. Ikuta MEK1/2 Induces STAT5-Mediated Germline Transcription of the TCR{gamma} Locus in Response to IL-7R Signaling J. Immunol., July 1, 2008; 181(1): 494 - 502. [Abstract] [Full Text] [PDF]

				L. Sun, K. Ma, H. Wang, F. Xiao, Y. Gao, W. Zhang, K. Wang, X. Gao, N. Ip, and Z. Wu JAK1 STAT1 STAT3, a key pathway promoting proliferation and preventing premature differentiation of myoblasts J. Cell Biol., October 8, 2007; 179(1): 129 - 138. [Abstract] [Full Text] [PDF]

				R. E. Schweppe, T. H. Cheung, and N. G. Ahn Global Gene Expression Analysis of ERK5 and ERK1/2 Signaling Reveals a Role for HIF-1 in ERK5-mediated Responses J. Biol. Chem., July 28, 2006; 281(30): 20993 - 21003. [Abstract] [Full Text] [PDF]

				F. A. Scholl, P. A. Dumesic, and P. A. Khavari Mek1 Alters Epidermal Growth and Differentiation Cancer Res., September 1, 2004; 64(17): 6035 - 6040. [Abstract] [Full Text] [PDF]

				T. T. Maliekal, R. J. Anto, and D. Karunagaran Differential Activation of Smads in HeLa and SiHa Cells That Differ in Their Response to Transforming Growth Factor-{beta} J. Biol. Chem., August 27, 2004; 279(35): 36287 - 36292. [Abstract] [Full Text] [PDF]

				J. R. Sevinsky, A. M. Whalen, and N. G. Ahn Extracellular Signal-Regulated Kinase Induces the Megakaryocyte GPIIb/CD41 Gene through MafB/Kreisler Mol. Cell. Biol., May 15, 2004; 24(10): 4534 - 4545. [Abstract] [Full Text] [PDF]

				B. E. Bobick and W. M. Kulyk The MEK-ERK Signaling Pathway Is a Negative Regulator of Cartilage-specific Gene Expression in Embryonic Limb Mesenchyme J. Biol. Chem., February 6, 2004; 279(6): 4588 - 4595. [Abstract] [Full Text] [PDF]

				Y.-W. Lin, S.-M. Chuang, and J.-L. Yang ERK1/2 Achieves Sustained Activation by Stimulating MAPK Phosphatase-1 Degradation via the Ubiquitin-Proteasome Pathway J. Biol. Chem., June 6, 2003; 278(24): 21534 - 21541. [Abstract] [Full Text] [PDF]

				A. S. Dhillon, S. Meikle, C. Peyssonnaux, J. Grindlay, C. Kaiser, H. Steen, P. E. Shaw, H. Mischak, A. Eychene, and W. Kolch A Raf-1 Mutant That Dissociates MEK/Extracellular Signal-Regulated Kinase Activation from Malignant Transformation and Differentiation but Not Proliferation Mol. Cell. Biol., March 15, 2003; 23(6): 1983 - 1993. [Abstract] [Full Text] [PDF]

				A. Mauro, C. Ciccarelli, P. De Cesaris, A. Scoglio, M. Bouche, M. Molinaro, A. Aquino, and B. M. Zani PKC{alpha}-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells J. Cell Sci., September 15, 2002; 115(18): 3587 - 3599. [Abstract] [Full Text] [PDF]

				H. Cha, E. K. Lee, and P. Shapiro Identification of a C-terminal Region That Regulates Mitogen-activated Protein Kinase Kinase-1 Cytoplasmic Localization and ERK Activation J. Biol. Chem., December 14, 2001; 276(51): 48494 - 48501. [Abstract] [Full Text] [PDF]

				S. D. Gross, A. L. Lewellyn, and J. L. Maller A Constitutively Active Form of the Protein Kinase p90Rsk1 Is Sufficient to Trigger the G2/M Transition in Xenopus Oocytes J. Biol. Chem., November 30, 2001; 276(49): 46099 - 46103. [Abstract] [Full Text] [PDF]

				H. Cha and P. Shapiro Tyrosine-phosphorylated Extracellular Signal-regulated Kinase Associates with the Golgi Complex during G2/M Phase of the Cell Cycle: Evidence for Regulation of Golgi Structure J. Cell Biol., June 18, 2001; 153(7): 1355 - 1368. [Abstract] [Full Text] [PDF]

				S. A. Walter, S. N. Guadagno, and J. E. Ferrell Jr. Activation of Wee1 by p42 MAPK In Vitro and in Cycling Xenopus Egg Extracts Mol. Biol. Cell, March 1, 2000; 11(3): 887 - 896. [Abstract] [Full Text]

				D. W. Abbott and J. T. Holt Mitogen-activated Protein Kinase Kinase 2 Activation Is Essential for Progression through the G2/M Checkpoint Arrest in Cells Exposed to Ionizing Radiation J. Biol. Chem., January 29, 1999; 274(5): 2732 - 2742. [Abstract] [Full Text] [PDF]

				A. S. Zolotukhin and B. K. Felber Nucleoporins Nup98 and Nup214 Participate in Nuclear Export of Human Immunodeficiency Virus Type 1 Rev J. Virol., January 1, 1999; 73(1): 120 - 127. [Abstract] [Full Text] [PDF]

				A. Dang, J. A. Frost, and M. H. Cobb The MEK1 Proline-rich Insert Is Required for Efficient Activation of the Mitogen-activated Protein Kinases ERK1 and ERK2 in Mammalian Cells J. Biol. Chem., July 31, 1998; 273(31): 19909 - 19913. [Abstract] [Full Text] [PDF]

				N. S. Duesbery, C. P. Webb, S. H. Leppla, V. M. Gordon, K. R. Klimpel, T. D. Copeland, N. G. Ahn, M. K. Oskarsson, K. Fukasawa, K. D. Paull, et al. Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor Science, May 1, 1998; 280(5364): 734 - 737. [Abstract] [Full Text]

				H.-Y. Lee, G. L. Walsh, M. I. Dawson, W. K. Hong, and J. M. Kurie All-trans-Retinoic Acid Inhibits Jun N-terminal Kinase-dependent Signaling Pathways J. Biol. Chem., March 20, 1998; 273(12): 7066 - 7071. [Abstract] [Full Text] [PDF]

				P. S. Shapiro and N. G. Ahn Feedback Regulation of Raf-1 and Mitogen-activated Protein Kinase (MAP) Kinase Kinases 1 and 2 by MAP Kinase Phosphatase-1 (MKP-1) J. Biol. Chem., January 16, 1998; 273(3): 1788 - 1793. [Abstract] [Full Text] [PDF]

				H. Schramek, E. Feifel, E. Healy, and V. Pollack Constitutively Active Mutant of the Mitogen-activated Protein Kinase Kinase MEK1 Induces Epithelial Dedifferentiation and Growth Inhibition in Madin-Darby Canine Kidney-C7 Cells J. Biol. Chem., April 25, 1997; 272(17): 11426 - 11433. [Abstract] [Full Text] [PDF]

				MeganJ. Robinson, M. Cheng, A. Khokhlatchev, D. Ebert, N. Ahn, K.-L. Guan, B. Stein, E. Goldsmith, and MelanieH. Cobb Contributions of the Mitogen-activated Protein (MAP) Kinase Backbone and Phosphorylation Loop to MEK Specificity J. Biol. Chem., November 22, 1996; 271(47): 29734 - 29739. [Abstract] [Full Text] [PDF]